$0.2322
0.011[4.97%]
At close: Apr 17
$0.2322
0[0.00%]
PreMarket: 7:38PM EDT
Portage Biotech
(NASDAQ:PRTG)Portage Biotech Stock (NASDAQ:PRTG), Analyst Ratings, Price Targets, Predictions
Portage Biotech Inc has a consensus price target of $22.33, established from looking at the 13 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and Cantor Fitzgerald on January 8, 2024, November 29, 2023, and September 7, 2023. With an average price target of $5.67 between HC Wainwright & Co., HC Wainwright & Co., and Cantor Fitzgerald, there's an implied 2340.42% upside for Portage Biotech Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Cantor Fitzgerald
Oppenheimer
Oppenheimer
B. Riley Securities
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Portage Biotech
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 01/08/2024 | PRTG | Buy Now | Portage Biotech | $0.23 | — | HC Wainwright & Co. | Robert Burns | — | Downgrade | Buy → Neutral | Get Alert |
| 11/29/2023 | PRTG | Buy Now | Portage Biotech | $0.23 | 2483.98% | HC Wainwright & Co. | Robert Burns | $9 → $6 | Maintains | Buy | Get Alert |
| 09/07/2023 | PRTG | Buy Now | Portage Biotech | $0.23 | 4637.3% | Cantor Fitzgerald | Li Watsek | → $11 | Reiterates | Overweight → Overweight | Get Alert |
| 08/31/2023 | PRTG | Buy Now | Portage Biotech | $0.23 | 4637.3% | Cantor Fitzgerald | Li Watsek | → $11 | Reiterates | Overweight → Overweight | Get Alert |
| 08/02/2023 | PRTG | Buy Now | Portage Biotech | $0.23 | 3775.97% | HC Wainwright & Co. | Robert Burns | $21 → $9 | Maintains | Buy | Get Alert |
| 08/01/2023 | PRTG | Buy Now | Portage Biotech | $0.23 | 4637.3% | Cantor Fitzgerald | Li Watsek | $16 → $11 | Maintains | Overweight | Get Alert |
| 12/01/2022 | PRTG | Buy Now | Portage Biotech | $0.23 | 8943.93% | HC Wainwright & Co. | Robert Burns | $22 → $21 | Maintains | Buy | Get Alert |
| 11/30/2022 | PRTG | Buy Now | Portage Biotech | $0.23 | 7651.94% | Oppenheimer | Matthew Biegler | $26 → $18 | Maintains | Outperform | Get Alert |
| 09/20/2022 | PRTG | Buy Now | Portage Biotech | $0.23 | 9374.59% | HC Wainwright & Co. | Robert Burns | $32 → $22 | Maintains | Buy | Get Alert |
| 03/07/2022 | PRTG | Buy Now | Portage Biotech | $0.23 | 13681.22% | HC Wainwright & Co. | Robert Burns | → $32 | Initiates | → Buy | Get Alert |
| 09/21/2021 | PRTG | Buy Now | Portage Biotech | $0.23 | 12819.9% | Oppenheimer | Kevin DeGeeter | — | Initiates | → Outperform | Get Alert |
| 09/02/2021 | PRTG | Buy Now | Portage Biotech | $0.23 | 17126.53% | B. Riley Securities | Justin Walsh | — | Initiates | → Buy | Get Alert |
| 08/19/2021 | PRTG | Buy Now | Portage Biotech | $0.23 | 14973.21% | Cantor Fitzgerald | — | — | Initiates | → Overweight | Get Alert |
FAQ
What is the target price for Portage Biotech (PRTG)?
The latest price target for Portage Biotech (NASDAQ: PRTG) was reported by HC Wainwright & Co. on January 8, 2024. The analyst firm set a price target for $0.00 expecting PRTG to fall to within 12 months (a possible -100.00% downside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Portage Biotech (PRTG)?
The latest analyst rating for Portage Biotech (NASDAQ: PRTG) was provided by HC Wainwright & Co., and Portage Biotech downgraded their neutral rating.
When was the last upgrade for Portage Biotech (PRTG)?
There is no last upgrade for Portage Biotech.
When was the last downgrade for Portage Biotech (PRTG)?
The last downgrade for Portage Biotech Inc happened on January 8, 2024 when HC Wainwright & Co. changed their price target from N/A to N/A for Portage Biotech Inc.
When is the next analyst rating going to be posted or updated for Portage Biotech (PRTG)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Portage Biotech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Portage Biotech was filed on January 8, 2024 so you should expect the next rating to be made available sometime around January 8, 2025.
Is the Analyst Rating Portage Biotech (PRTG) correct?
While ratings are subjective and will change, the latest Portage Biotech (PRTG) rating was a downgraded with a price target of $0.00 to $0.00. The current price Portage Biotech (PRTG) is trading at is $0.23, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.